Tuesday, December 2, 2008 - 7:47PM EST

Clinical Trials

41. Mometasone furoate improves congestion in patients with moderate-to-severe seasonal allergic rhinitis.

Author
Berger WE; Nayak AS; Staudinger HW;
Institution
Department of Pediatrics, Division of Allergy and Immunology, University of California, Irvine, 92691, USA. werber@uci.edu
Journal
Ann Pharmacother. 2005 Dec;39(12):1984-9. Epub 2005 Nov 8.
Abstract URL
Click here to view abstract

42. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis.

Author
Dahl R; Stender A; Rak S;
Institution
Department of Respiratory Diseases, Aarhus University Hospital, Aarhus, Denmark.
Journal
Allergy. 2006 Feb;61(2):185-90.
Abstract URL
Click here to view abstract

43. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis.

Author
Chervinsky P; Nayak A; Rooklin A; Danzig M;
Institution
Northeast Medical Research Associates, 49 State Road, Suite 203, North Dartmouth, MA 02747, USA.
Journal
Allergy Asthma Proc. 2005 Sep-Oct;26(5):391-6.
Abstract URL
Click here to view abstract

44. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.

Author
Roberts G; Hurley C; Turcanu V; Lack G;
Institution
University Child Health, University of Southampton, Hants, UK. g.c.roberts@soton.ac.uk
Journal
J Allergy Clin Immunol. 2006 Feb;117(2):263-8.
Abstract URL
Click here to view abstract

45. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.

Author
Raphael GD; Angello JT; Wu MM; Druce HM;
Institution
Pfizer Consumer Healthcare, Morris Plains, New Jersey 07950, USA.
Journal
Ann Allergy Asthma Immunol. 2006 Apr;96(4):606-14.
Abstract URL
Click here to view abstract

46. Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo.

Author
Hampel FC Jr; Ratner PH; Amar NJ; van Bavel JH; Mohar D; Fairchild CJ; Wall GM; Brubaker MJ; Drake M; Crenshaw KM;
Institution
Central Texas Health Research, New Braunfels and San Antonio, Texas, 78130, USA. fchampel@aol.com
Journal
Allergy Asthma Proc. 2006 May-Jun;27(3):202-7.
Abstract URL
Click here to view abstract

47. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.

Author
Berger WE; Lumry WR; Meltzer EO; Pearlman DS;
Institution
Allergy and Asthma Associates of Southern California, Mission Viejo, California 92691, USA. WEBerger@uci.edu
Journal
Allergy Asthma Proc. 2006 May-Jun;27(3):214-23.
Abstract URL
Click here to view abstract

48. Is the usage of intranasal glucocorticosteroids alone in allergic rhinitis sufficient?

Author
Can D; Tanac R; Demir E; Gulen F; Veral A;
Institution
Division of Pediatric Allergy and Pulmonology, Behcet Uz Children Hospital, Izmir, Turkey. ddcan15@hotmail.com
Journal
Allergy Asthma Proc. 2006 May-Jun;27(3):248-53.
Abstract URL
Click here to view abstract

49. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.

Author
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Sackesen C; Kalayci O;
Institution
Pediatric Allergy and Asthma Unit, Hacettepe University School of Medicine, Hacettepe, Ankara, Turkey.
Journal
Pediatr Allergy Immunol. 2006 Sep;17(6):396-407.
Abstract URL
Click here to view abstract

50. Multiple daily administrations of low-dose sublingual immunotherapy in allergic rhinoconjunctivitis.

Author
Bordignon V; Burastero SE;
Institution
Bassano del Grappa (VI), Italy.
Journal
Ann Allergy Asthma Immunol. 2006 Aug;97(2):158-63.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6